Forum für Wissenschaft, Industrie und Wirtschaft
Hauptsponsoren:     Siemens  n-tv 
Datenbankrecherche:

Fachgebiet (optional):

 

Home Fachgebiete Medizin Gesundheit Nachricht

Immune system activated in schizophrenia

nächste Meldung
20.11.2009

Researchers at the Swedish medical university Karolinska Institutet have discovered that patients with recent-onset schizophrenia have higher levels of inflammatory substances in their brains. Their findings offer hope of being able to treat schizophrenia with drugs that affect the immune system.

Anzeige

Scientists at Karolinska Institutet have now been able to analyse inflammatory substances in the spinal fluid of patients with schizophrenia, instead of, as in previous studies, in the blood. The results show that patients with recent-onset schizophrenia have raised levels of a signal substance called interleukin-1beta, which can be released in the presence of inflammation. In the healthy control patients, this substance was barely measurable.


"This suggests that the brain's immune defence system is activated in schizophrenia," says Professor Göran Engberg, who led the study. "It now remains to be seen whether there is an underlying infection or whether the immune system is triggered by some other means."

According to the dominant hypothesis, schizophrenia is related to an overactive dopamine system. Previous studies have shown that interleukin-1beta can upset the dopamine system in rats in a similar way to schizophrenia in humans.

"We would have made terrific progress if we were one day able to treat schizophrenia patients with immunotherapy, as it might then be possible to interrupt the course of the disease at an early stage of its development," says Professor Engberg.

The group is now studying if the inflammatory process is only activated in connection with the development of schizophrenia, or whether chronic patients exhibit the same phenomenon.

Publication
J Söderlund, J Schröder, C Nordin, M Samuelsson, L Walther-Jallow, H Karlsson, S Erhardt, G Engberg

Activation of brain interleukin-1² in schizophrenia
Molecular Psychiatry, vol.14; no. 12; November 2009

Katarina Sternudd | Quelle: EurekAlert!
Weitere Informationen: www.ki.se

nächste Meldung

Weitere Nachrichten aus der Kategorie Medizin Gesundheit:

nachricht Study details machinery of immune protection against inflammatory diseases like colitis
19.03.2010 | St. Jude Children's Research Hospital

nachricht Hormonerkrankungen durch Weichmacher
19.03.2010 | Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften

Alle Nachrichten aus der Kategorie Medizin Gesundheit >>>

Anzeige

B2B Suche

Produkt / Dienstleistung
Firma / Organisation

Anzeige

Aktuell

Laserdrucker-Emissionen schädigen Lungenzellen

19.03.2010 | Studien Analysen

Rückenschmerzen: Was kostet Lebensqualität?

19.03.2010 | Studien Analysen

The Institute for Ocean Conservation Science applauds IUCN's reclassifcation of beluga sturgeon

19.03.2010 | Ökologie Umwelt- Naturschutz

Innovations Report TV
Reportagen, Interviews und
Video-Highlights auf:

www.innovations-report.tv

... in Kooperation mit
Science-TV & Inventions-TV
VideoLinks
B2B-VideoLinks
Weitere VideoLinks >>>

Veranstaltungen

China-Woche 2010

19.03.2010 | Veranstaltungsnachrichten

Baufinanzierer setzen auf einen starken Vertrieb

19.03.2010 | Veranstaltungsnachrichten

Heidelberger Innovationsforum: Cleantech & Green IT

19.03.2010 | Veranstaltungsnachrichten

Live-Mitschnitte, Interviews und Hintergründe von den Meinungs-
führern aus Politik und Wirtschaft jetzt auf www.euroforum.tv

FindAndHelp